Screening solutions for the risk of the most prevalent hereditary cancers
(Only one test. Results returned in 14 days)
Over
0.0million new cases of cancer have been diagnosed (2020)
million deaths due to cancer (2020)
Over
0Vietnamese people die from cancer every day
Every
0people 1
person carries a cancer-causing gene (*)
- Source: Global Cancer Statistics 2020
- (*) Source: Data according to research by the Medical Genetics Institute — Gene Solutions
Genetics
Lifestyle
Environment
Major etiologies of cancer
The oncoSureTM genetic cancer screening test supports the analysis of cancer-related genetic components. Learn more about the cancer detection, monitoring, and treatment tests offered by Gene Solutions.The development of cancer in individuals results from the interaction of three factors:
Why should you take the oncoSure hereditary cancer screening test?
Advantages of oncoSure test
The results of the test allow for early detection of hereditary cancer risk:
- Active cancer prevention includes medication treatment, and preventive surgery to reduce cancer risk.
- Active screening helps early disease diagnosis, significantly improving cancer treatment outcomes.
Support consultations with geneticists and oncologists and free testing for three close relatives.
(*) Source: Statistics adapted from the American Cancer Society's publication, Cancer Facts & Figures 2020, the ACS website, and the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) Program (all sources accessed January 2020)
Scope of the test
Genetic mutations associated with hereditary cancer
No Hereditary cancer Testing genes 01 Skin Cancer BAP1, BRAF, BRCA2, CBL, CDK4, CDKN2A, CYLD, DDB2, DKC1, ERCC2, ERCC3, ERCC4, ERCC5, FH, FLCN, HNF1A, KITLG, MAP2K1, MAP2K2, MITF, NRAS, POLH, PTCH1, PTEN, RECQL4, TINF2, TP53, WRN, XPA, XPC 02 Acute Leukemia (blood cancer) ANKRD26, BUB1B, CBL, CEBPA, CEP57, EGFR, ELANE, ETV6, FANCA, FANCB, FANCC, FANCD2, FANCE, FANCF, FANCG, FANCI, FANCL, FANCM, GATA2, NRAS, PAX5, PDGFRA, PRF1, PTPN11, RUNX1, SPRED1, SRP72, WT1 03 Colorectal Cancer APC, AXIN2, BLM, BMPR1A, CBL, CDH1, CHEK2, DKC1, EPCAM, EXO1, GREM1, MLH1, MLH3, MSH2, MSH6, MUTYH, NRAS, NTHL1, PMS1, PMS2, POLD1, PTEN, SMAD4, SOS1, STK11, TP53 04 Breast Cancer ATM, BARD1, BLM, BRCA1, BRCA2, CDH1, CHEK2, DKC1, MRE11A, NBN, NF1, PALB2, PMS1, PPM1D, PTEN, RAD50, SHOC2, SLX4, STK11, TP53, XRCC2 05 Lung Cancer BRAF, DICER1, DKC1, EGFR, ERCC1, ERCC2, ERCC3, ERCC4, ERCC5, FLCN, KRAS, MAP2K1, MAP2K2, NRAS, RET, SMARCA4, SOS1, TERC, TERT 06 Kidney Cancer BAP1, BUB1B, CDKN1C, CEP57, DICER1, DIS3L2, EPCAM, FH, HNF1A, MET, MLH1, MSH2, MSH6, PMS2, SDHB, VHL, WT1 07 Pancreatic Cancer APC, BMPR1A, BRCA1, BRCA2, CDK4, CDKN2A, DKC1, EPCAM, MLH1, MSH2, MSH6, PALB2, PMS2, SMAD4, STK11, TP53 08 Ovarian Cancer BRCA1, BRCA2, BRIP1, DICER1, EPCAM, ERCC1, MLH1, MRE11A, MSH2, MSH6, MUTYH, PALB2, PMS2, RAD51C, STK11, TP53 09 Stomach Cancer APC, BMPR1A, CDH1, EPCAM, KIT, MLH1, MSH2, MSH6, NSUN2, PMS2, PTEN, SMAD4, STK11, TP53 10 Bladder Cancer ATM, FANCA, FANCB, FANCC, FANCD2, FANCE, FANCF, FANCG, FANCI, FANCL, FANCM, HRAS, RAF1 11 Endometrial Cancer CBL, CDKN1C, EPCAM, FH, MLH1, MLH3, MSH2, MSH6, PMS2, PTEN, STK11, TP53 12 Prostate Cancer BRCA1, BRCA2, EPCAM, EZH2, HOXB13, MLH1, MSH2, MSH6, PALB2, PMS2, TP53 13 Head and Neck Cancer FANCA, FANCB, FANCC, FANCD2, FANCE, FANCF, FANCG, FANCI, FANCL, FANCM 14 Brain Cancer ERCC2, ERCC3, ERCC4, ERCC5, NF1, NSD1, PHOX2B, SUFU 15 Neural Paraganglioma RET, SDHA, SDHAF2, SDHB, SDHC, SDHD, VHL 16 Biliary Tract Cancer BAP1, BRAF, KRAS, NRAS, TSC1, TSC2 17 Thyroid Cancer CDKN1C, DICER1, RET, TINF2, WRN 18 Bone Cancer EXT1, EXT2, RECQL4, SMARCB1 19 Multiple Endocrine Neoplasias CDKN1B, MEN1, PRKAR1A, RET 20 Sarcoma BUB1B, CEP57, HRAS 21 Liver Cancer GPC3, HNF1A 22 Small Bowel Cancer BMPR1A, KIT 23 Pituitary Tumor AIP, DKC1 24 Neuroblastoma ALK, HRAS 25 Nerve Fibroma NF1, NF2 26 Adrenal Myeloma MAX, RET, TMEM127 27 Parathyroid Cancer CDC73 28 Retinoblastoma RB1 29 Esophageal Cancer RHBDF2 30 Multiple Myeloma BRAF
Show more
Testing candidates
Testing candidates
PERSONAL HISTORY
FAMILY HISTORY
CONCERNED ABOUT THE POSSIBILITY OF HEREDITARY CANCER INHERITANCE
(*) Source: National Institutes of Health.
What do you get from the test package?
17 - 133 genes associated with 15 - 30 hereditary cancers are analyzed
Detects mutations in family-inherited genes that increase the risk of common types of cancer. The test results help you evaluate the probability that you will have certain cancers for yourself and your family
Genetic counseling from geneticists
The team of experts and geneticists at Gene Solutions are always available to accompany you before and after each test and provide recommendations based on the results
Modify the treatment plan
The results assist in tracking cancer/chronic disease progression and planning effective interventions. In addition, it is possible to improve the efficacy of treatment by choosing an appropriate regimen
Guaranteed quality in every result
Next-generation sequencing technology (Illumina) from the United States was developed by Vietnam's leading medical advisors and a team of professionals. In only 14 days, a high-quality lab that complies with ISO standards will provide you with more than 99-percent-correct test results
Simple to do and cost-effective
The USA standard DNA sampling kit, which allows you to collect samples at home in less than a minute, is painless and incredibly convenient
Free testing for family members
If the initial test identifies a mutation, three family members will receive free testing. Take the initiative to prevent and protect your family's health
Testing process
Pre-test counselling
Blood collection and extracellular DNA separation
Sequencing of cell-free DNA
Returning results and post-test counselling
Genetic consultation with our doctors
Besides you and your family before and after the test.